Diagnostics

  • Diagnostic firm says ‘mini lab’ can test for new Omicron Covid variant

    Diagnostic firm QuantuMDx says its 'mini laboratory', which carries out rapid Covid testing, is able to detect all known variants of COVID-19, including the new Omicron variant. QuantuMDx has confirmed that both its SARS-CoV-2 assays for open PCR platforms and its rapid PCR device, Q-POC™, as well as its future respiratory panel (SARS-CoV-2, Flu A, Flu B [...]

  • Nottingham University Hospital Trust deploys patient accelerator

    The UK's Nottingham University Hospitals (NUH) NHS Trust has selected Tisski to design, develop and deploy a patient accelerator. Dr. Sameedha Rich-Mahadkar, deputy director of strategy Nottingham University Hospitals NHS Trust said the accelerator will deliver a much-improved referrals and financial management process for its Private Patient and Overseas Visitors unit. “The Trust has an ambition to deliver outstanding health outcomes and patient and staff experience across all [...]

  • QuantuMDx secures £15m equity investment from Vita Spring

    QuantuMDx  has secured a £15m equity investment from Vita Spring, a Hong Kong-based venture capital firm focused on early and growth stage medical companies with disruptive technologies and global market potential. QuantuMDx's Q-POC is a portable, PCR device offering rapid, sample-to-answer, molecular diagnostic testing at the point of care, with results in approximately 30 minutes. [...]

  • Teleradiology company creates first UK share scheme for radiologists

    Radiology start-up Hexarad has become the first UK teleradiology company to offer a share scheme to its radiologists. Radiologists reporting scans for Hexarad are invited to join an exclusive share scheme. There will be no buy-in required or any additional costs associated with owning the shares. The share scheme has been set up in response [...]

  • NHS provides patients with home blood pressure monitors

    The NHS has sent more than 65,000 home blood pressure monitors to patients in the UK. The devices are being made available to 220,000 people who have been diagnosed with uncontrolled high blood pressure. Patients wrap the small machine around their upper arm to measure their blood pressure reading and send the reading to their [...]

  • NHS to receive £250m to digitise diagnostics care

    The UK's Department of Health and Social Care (DHSC) will provide the NHS with £248m to invest in technology. Health bosses say this will deliver more diagnostic tests, checks and scans to help provide faster diagnosis of health conditions, earlier treatment and reduced waiting lists. A spokesperson for DHSC said the investment will reduce the [...]

  • New blood test to identify type 1 diabetes

    A simple blood test for people with Type 1 diabetes which may enable some patients to stop taking insulin will be rolled out in Scotland. Health bosses say Scotland is the first country in the world to introduce this test which launched in hospital diabetes centres on November 1. Aimed to improve the accuracy of [...]

  • Spin-out company developing wound infection tests

    A quick and simple test for bacterial infections could be a step closer to market. The University of Bath and University Hospitals Bristol and Weston NHS Foundation Trust, England, is launching a new spin-out company that is creating a quick and simple test for diagnosing bacterial infections in wounds, based on technology developed at the University’s Department of [...]

  • Rare disease charities join health information provider

    Health information provider Cognitant has added five rare disease charities to its bank of content partners. The provider is working to become the go-to source for trusted health information using its digital platform, Healthinote. A spokesperson for the company said Healthinote is integrated with the triaging and remote consultation company, eConsult, which helps provide GPs [...]

  • Prostate cancer urine test identifies good prognosis patients

    Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at ‘intermediate risk’ who can safely avoid immediate treatment and benefit from ‘active surveillance’ instead. A new pilot study published today (October 3) reveals how urine biomarkers can show the amount of significant cancer in a prostate, highlighting with more certainty which men need treatment. Previously, [...]